-+ 0.00%
-+ 0.00%
-+ 0.00%

Virax Biolabs Group Announces 1-For-25 Reverse Stock Split, Effective June 26

Benzinga·06/24/2026 13:04:22
Listen to the news

Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today announced that the board of directors of the Company approved a share consolidation of the Company's authorized, issued and outstanding ordinary shares of US$0.001 par value each at a ratio of 1-for-25 effective 26 June 2026 (the "Share Consolidation").